Until now, there has not been a widely accepted biochemical biomarker for IPF [1,2,3], although certain macromolecules in the blood—mucin-1/KL-6 in particular—have been proposed as potential candidates [27,31,35,36,37]. Here, MUC1 is linked to idiopathic pulmonary fibrosis.